24
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Expression of the Multidrug Transporter P-glycoprotein is Highly Correlated with Clinical Outcome in Childhood Acute Lymphoblastic Leukemia: Results of a Long-Term Prospective Study

, , , , , , & show all
Pages 309-314 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ana Carolina Rabello de Moraes, Marley Aparecida Licínio, Júlio Araújo Zampirolo, Susie Coutinho Liedke, Joanita Ângela Gonzaga Del Moral, Marcos José Machado, Maria Luiza Bazzo & Maria Cláudia Santos da Silva. (2012) Evaluation of multidrug resistance in 46 newly diagnosed patients with acute leukemia. Hematology 17:2, pages 59-65.
Read now
Arcadi I. Svirnovski, Tatsiana V. Shman, Tatsiana F. Serhiyenka, Valery P. Savitski, Victoria V. Smolnikova & Uladzimir U. Fedasenka. (2009) ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Hematology 14:4, pages 204-212.
Read now

Articles from other publishers (19)

Bahareh Samii, Abbas Jafarian, Mohamad Rabbani, Behzad Zolfaghari, Soheila Rahgozar & Elnaz Pouraboutaleb. (2023) The effects of Astragalus polysaccharides, tragacanthin, and bassorin on methotrexate-resistant acute lymphoblastic leukemia. Research in Pharmaceutical Sciences 18:4, pages 381-391.
Crossref
Nathália Moreno Cury, Tobias Mühlethaler, Angelo Brunelli Albertoni Laranjeira, Rafael Renatino Canevarolo, Priscila Pini Zenatti, Daniel Lucena-Agell, Isabel Barasoain, Chunhua Song, Dongxiao Sun, Sinisa Dovat, Rosendo Augusto Yunes, Andrea Enrico Prota, Michel Olivier Steinmetz, José Fernando Díaz & José Andrés Yunes. (2019) Structural Basis of Colchicine-Site targeting Acylhydrazones active against Multidrug-Resistant Acute Lymphoblastic Leukemia. iScience 21, pages 95-109.
Crossref
Rosanna K. Jackson, Julie A. E. Irving & Gareth J. Veal. (2016) Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia. British Journal of Haematology 173:1, pages 13-24.
Crossref
Alexander V. LyubimovSteven J. Wolf & Caroline G. Lee. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 40 .
Hairong Huo, Pellegrino G. Magro, E. Christy Pietsch, Brijesh B. Patel & Kathleen W. Scotto. (2010) Histone Methyltransferase MLL1 Regulates MDR1 Transcription and Chemoresistance . Cancer Research 70:21, pages 8726-8735.
Crossref
Maureen M. O'Brien, Norman J. Lacayo, Bert L. Lum, Smita Kshirsagar, Steven Buck, Yaddanapudi Ravindranath, Mark Bernstein, Howard Weinstein, Myron N. Chang, Robert J. Arceci, Branimir I. Sikic & Gary V. Dahl. (2010) Phase I study of valspodar (PSC‐833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: A report from the Children's Oncology Group. Pediatric Blood & Cancer 54:5, pages 694-702.
Crossref
Maria A.A. Cortez, Carlos A. Scrideli, José A. Yunes, Elvis T. Valera, Sílvia R.C. Toledo, Patrícia C.B. Pavoni‐Ferreira, Maria L.M. Lee, Antônio S. Petrilli, Silvia R. Brandalise & Luiz G. Tone. (2009) mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death. Pediatric Blood & Cancer 53:6, pages 996-1004.
Crossref
S. Balamurugan, D. Sugapriya, P. Shanthi, V. Thilaka, S. Venkatadesilalu, V. Pushpa & M. Madhavan. (2008) Multidrug resistance 1 gene expression and AgNOR in childhood acute leukemias. Indian Journal of Hematology and Blood Transfusion 23:3-4, pages 73-78.
Crossref
David A. Estes, Debbie M. Lovato, Hadya M. Khawaja, Stuart S. Winter & Richard S. Larson. (2007) Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples. British Journal of Haematology 139:1, pages 20-30.
Crossref
M. Kourti, N. Vavatsi, N. Gombakis, V. Sidi, G. Tzimagiorgis, T. Papageorgiou, D. Koliouskas & F. Athanassiadou. (2007) Expression of Multidrug Resistance 1 (MDR1), Multidrug Resistance-Related Protein 1 (MRP1), Lung Resistance Protein (LRP), and Breast Cancer Resistance Protein (BCRP) Genes and Clinical Outcome in Childhood Acute Lymphoblastic Leukemia. International Journal of Hematology 86:2, pages 166-173.
Crossref
T. V. Shman, V. P. Savitskii, M. P. Potapnev & O. V. Aleinikova. (2006) Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia. Bulletin of Experimental Biology and Medicine 141:6, pages 727-730.
Crossref
Katrien Swerts, Barbara De Moerloose, Catharina Dhooge, Geneviève Laureys, Yves Benoit & Jan Philippé. (2006) Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia. European Journal of Cancer 42:3, pages 295-309.
Crossref
George S. Sheppard & Jennifer J. Bouska. (2005) Why optimize cancer drugs for ADMET?. Drug Discovery Today: Therapeutic Strategies 2:4, pages 343-349.
Crossref
Geraldo Barroso Cavalcanti, Flavia da Cunha Vasconcelos, Giselle Pinto de Faria, Marcos Ant�nio Maur�cio Scheiner, Jane de Almeida Dobbin, Claudete Esteves Klumb & Raquel C. Maia. (2004) Coexpression of p53 protein and MDR functional phenotype in leukemias: The predominant association in chronic myeloid leukemia. Cytometry 61B:1, pages 1-8.
Crossref
Sabine L.A Plasschaert, Willem A Kamps, Edo Vellenga, Elisabeth G.E de Vries & Eveline S.J.M de Bont. (2004) Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?. Cancer Treatment Reviews 30:1, pages 37-51.
Crossref
R W Stam, M M van den Heuvel-Eibrink, M L den Boer, M E G Ebus, G E Janka-Schaub, J D Allen & R Pieters. (2003) Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein. Leukemia 18:1, pages 78-83.
Crossref
William W. Johnson. 2004. Cellular Drug Delivery. Cellular Drug Delivery 129 162 .
C Martin, J Walker, A Rothnie & R Callaghan. (2003) The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models. British Journal of Cancer 89:8, pages 1581-1589.
Crossref
. (2002) Current Awareness in Hematological Oncology. Hematological Oncology 20:4, pages 189-196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.